Jordan Julie bought NGNE
January 16, 2024 · Form 4 insider transaction
Jordan Julie bought 75,000 shares of Neurogene Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
75,000
Price
$0.00
Total value
N/A
InsiderJordan Julie
RoleOfficer
CompanyNeurogene Inc. (NGNE)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 16, 2024
Filing dateJanuary 18, 2024
Shares owned after75,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents the right to purchase 75,000 shares of common stock of the Issuer, of which 25% vests on the first anniversary of the grant date and the remainder vests in equal monthly installments through January 16, 2028, subject to the reporting person's continued service to the Issuer through each applicable vesting date.